Kaye Reiter, PhD Pluristyx, Inc.

Kaye D. Reiter, Ph.D., JD has over ten years of biotech law experience, counseling pharmaceutical companies, and academic and non-profit institutions. She has substantial experience in preparing patent landscape, freedom to operate, and commercialization analyses; assessing intellectual property (IP); identifying strategic partners for growth and negotiating agreements that may develop from those activities. Kaye obtained her Ph.D. in molecular biology from the University of California, Berkeley and then researched a large pharmaceutical company before attending law school at the University of Washington.

After serving as patent associate for both Wilson Sonsini Goodrich and Rosati and Davis Wright Tremaine, Dr. Reiter served as Senior Licensing Associate and Technology Manager at the Fred Hutchinson Cancer Research Center (FHCRC), where she played a significant role in negotiating several high-impact patent licenses and in promoting the establishment of a number of life science companies, including Juno Therapeutics, Nohla Therapeutics, and Rocket Pharma. Dr. Reiter is currently General Counsel for Pluristyx, Inc., an advanced tools company specializing in cell therapy consulting, contract development, and stem cell manufacturing.